Welcome!

Search Authors: Pat Romanski, Carmen Gonzalez, Elizabeth White, Aditya Banerjee, Sematext Blog

News Feed Item

Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024

LONDON, Feb. 17, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024

Report Details

Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024 - your guide to developments, opportunities and revenues

Where is the pharmaceutical anti-counterfeiting industry heading? Visiongain's brand new report lets you assess forecasted sales at overall world market, submarket, and national level to 2024.

Our 169 page study investigates technologies to tackle drug counterfeiters. Discover the most lucrative areas in that industry and market, seeing future outlooks.

Forecasts from 2014-2024 and other analyses show you commercial prospects

Besides revenue forecasting to 2024, our new study provides you with historical data, recent results, growth rates, and market shares. There you find original analyses, with business outlooks and developments (R&D). Discover qualitative analyses (SWOT and STEP), company profiles and commercial developments. You also receive two interviews, and 90 tables, figures and charts

You will find prospects for key technology submarkets

In addition to analyses of the overall world market, you see revenue forecasting of five technology submarkets to 2024:
• RFID (radio frequency identification)
• Security printing
• Taggants
• Holograms/OVD (optical variable devices)
• Other pharma anti-counterfeiting technologies

Our investigation shows business research and analysis with individual revenue forecasts and discussions.

Prospects for leading countries are shown to 2024

Events and progress worldwide will influence the market, especially rising demand for supply chain security measures such as track-and-trace systems. Growth in this market will be fuelled by government mandates requiring serialisation solutions on products.

You discover individual revenue forecasts to 2024 for these geographical markets:
• US
Japan
Germany, France, UK, Italy and Spain (EU5 Countries, as a group)
Brazil
Russia
India
China
• RoW

The expected launch of new technologies from 2013 onwards will benefit regional and national markets. Greater uptake of existing technology worldwide will also stimulate the industry and market.

Companies and overall 2016 market revenue - what predicted growth?

Overall world revenue for pharmaceutical anti-counterfeiting technologies will reach $1.11bn in 2014. Rising concerns about counterfeit drugs worldwide will stimulate demand for drug security, authentication and verification solutions.

Our work profiles leading companies, assessing their technologies and products. You will see which technologies and organisations hold greatest potential.

In particular, we profile these leading organisations:
• 3M
• Authentix
• Alien Technology
• Colorcon
• NanoGuardian
• Thermo Scientific
• Angstrom Technologies
• AlpVision
Avery Dennison
• Chesapeake
• Covectra
• Everest Holovisions
• InkSure Technologies
• Covectra
• Intermec
• TruTag Technologies
• UPM Raflatac
• Zebra Technologies

What issues decide the future of the industry and market?

Our study lets you assess industry trends and outlooks. You will find discussions of many issues and developments, including R&D:
• Parallel trade of medical products
• Activities of trade bodies and governmental organisations
• Security and efficiency of the pharma supply chain
• Wholesalers and other pharma intermediaries
• Actions taken by pharma companies
• Trading channels and drug counterfeiters
• Standards, regulations and policies

You see discussions of social, technological, economic and political matters, with emphasis on competing organisations and those shaping policy. Find out what the future holds.

Our investigation gives you multi-level business research and analysis with sales forecasts. You will see how the industry and market can perform from 2014 to 2024.

How the Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024 report helps you

In summary, our report gives you the following knowledge:
• Revenues forecasts to 2024 for the overall world pharmaceutical anti-counterfeiting technologies market and 5 submarkets - discover the industry's prospects
• Revenues forecasts to 2024 for 5 pharmaceutical anti-counterfeiting technologies submarkets - discover promising areas for investments and revenues
• Market forecasting to 2024 for the 8 key regions: US, Japan, leading EU countries (Germany, France, the UK, Italy and Spain), India, China, Brazil and Russia
• Profiles of 17 prominent companies - assess product ranges, developments and strategies
• Competition and opportunities - see what factors affect the pharmaceutical anti-counterfeiting market, learning what shapes its future, esp. prospects for sustaining and developing business
• Opinions from our survey, seeing interviews with leading industry experts AlpVision and also a Leading Anti-counterfeiting Technologies Company Based in the US.

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed on business intelligence.

1. Executive Summary

1.1 Market Highlights
1.2 Overview of the Report Content
1.3 Research and Analysis Methods
1.4 Glossary of Terms Related to Pharmaceutical Anti-counterfeiting Technologies

2. Introduction to Pharmaceutical Counterfeiting

2.1 Drug Counterfeiting: A Thorn in the Side of the Pharma Industry
2.1.1 Regional Differences Hindering Information Exchange
2.1.2 Rising Counterfeiting Incidents in Developed Regions
2.2 The Most Commonly Counterfeited Drugs
2.3 Types of Counterfeit Drugs
2.3.1 Substandard Pharmaceutical Products as Counterfeits
2.3.2 Global Outsourcing of Active Pharmaceutical Ingredients (APIs)
2.3.2.1 Heparin Contamination
2.3.2.2 Stricter Enforcement needed for API Control
2.4 Why are Drugs Counterfeited?
2.4.1 Methods of Producing Pharmaceutical Counterfeits
2.4.2 Moving Counterfeits into the Pharmaceutical Supply Chain
2.4.3 Corruption Within the Pharmaceutical Distribution System
2.5 The Internet and its Role in Pharmaceutical Counterfeiting
2.5.1 Online Pharmacies: A Cheap Distribution System for Pharma Counterfeits
2.5.2 Legal Online Pharmacies: A Convenient and Quick Way of Dispensing Medication
2.5.3 Verifying the Authenticity of Online Pharmacies
2.6 Pharmaceutical Counterfeiting: The Global Costs
2.6.1 The Impact of Pharmaceutical Counterfeiting on Consumers
2.6.2 The Impact of Counterfeiting on Healthcare Providers
2.6.3 The Impact of Counterfeiting on Pharma Manufacturers
2.6.4 The Impact of Pharmaceutical Counterfeiting on Governments
2.6.5 The Impact of Counterfeiting on the Global Pharmaceutical Industry
2.6.5.1 Operation Pangea: Europol's Fight Against Counterfeiting
2.6.5.2 Legislative Deficiencies Aiding Counterfeiting Operations
2.7 Factors Fuelling Pharmaceutical Counterfeiting
2.7.1 An Erratic Supply or Shortage of Drugs Promotes Counterfeiting
2.7.2 Price Differentials and High Price Medicines Drive People to Cheaper Counterfeit Alternatives
2.7.3 Drug Misuse Creates a Market for Counterfeiting
2.7.4 Trade through Free-Trade Zones/Free Ports Is an Important Route for Counterfeiters
2.7.5 The Trade of Pharmaceuticals through Several Intermediaries Helps Hide Counterfeit Drugs
2.7.6 Counterfeiters Target Developed Markets
2.7.7 Parallel Trade - a Counterfeiting Route in Europe

3. Leading Technologies and Applications

3.1 Passive Technologies
3.1.1 Security Inks as Anti-counterfeiting Technologies
3.1.2 Holograms as Anti-counterfeiting Technologies
3.1.3 Visual Inspection as the First Line of Defence Against Drug Counterfeiting
3.1.4 Overt and Hidden Imaging
3.2 Active Technologies
3.2.1 Electromagnetic Tags - Radio Frequency Identification (RFID) as Anti-counterfeiting Technologies
3.2.2 Taggants as Anti-counterfeiting Technologies
3.2.3 Mass Encoding Technology
3.2.3.1 Digital Mass Serialisation Technology (DMS)
3.2.3.2 Digital Mass Encryption (DME)
3.2.3.3 Barcode Applications: Serialisation is Key

4. Leading Companies in the Pharmaceutical Anti-counterfeiting Technologies Market

4.1 3M: A Diversified Technology Multinational
4.2 Alien Technology: RFID Technology Specialist
4.3 AlpVision: Cryptoglyph Security Solution
4.3.1 Fingerprint: A 'Read Only' Technology
4.3.2 Krypsos Platform
4.3.3 Cryptoglyph
4.3.4 AlpVision: Integration of Phone Applications Important for Future Growth
4.4 Angstrom Technologies - Security Inks
4.5 Authentix: Product Authentication and Brand Protection
4.5.1 Product-specific Track-and-Trace Solutions
4.5.2 Packaging Solutions
4.6 Avery Dennison: RFID Technologies Expert
4.7 Colorcon
4.7.1 Colorcon's Taggants: On-Dose ID
4.7.2 Colorcon's Brand Enhancement Service
4.8 Chesapeake: Acquired by The Caryle Group
4.9 Covectra
4.9.1 Covectra's Authenti-Track System for Product Tracing
4.9.2 Covectra's ControlTrack System for Combating Opioid Drug Diversion
4.10 Everest Holovisions
4.11 InkSure Technologies: Leader in Cloud-based Authentication
4.12 Intermec: A Workflow Performance Company
4.12.1 Automatic Information Data Capture
4.12.2 Will Recent Acquisitions Spell an Uncertain Future?
4.13 NanoGuardian
4.13.1 NanoCodes: Data Carriers of Limitless Potential
4.13.2 NanoGuardian's Global Licensing Agreement with Capsugel
4.13.3 The Closed-Loop Protection System
4.13.4 Major Players Showing Interest In NanoGuardian's Technologies
4.14 ThermoFisher Scientific
4.14.1 Acquisition of Ahura Scientific
4.14.2 Continous Growth and Expansion into Emerging Markets
4.14.3 ThermoFisher Scientific's TruScan Technology
4.15 TruTag Technologies
4.15.1 TruTag's Silica Microtag Technology
4.16 UPM Raflatac
4.17 Zebra Technologies

5. Global Pharmaceutical Anti-counterfeiting Technologies Market 2014-2024

5.1 Pharmaceutical Anti-counterfeiting Technologies: Market Overview
5.1.1 Size of the Pharmaceutical Anti-counterfeiting Technologies Market in 2012 and
2013
5.1.2 Global Pharmaceutical Anti-counterfeiting Technologies Market: Growth Trends
5.1.3 Global Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2012-2017
5.1.4 Global Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2017-2024
5.1.5 Changing Market Shares by Sector, 2012-2024
5.2 Pharmaceutical RFID Market Forecast 2012-2024
5.3 Pharmaceutical Security Printing Market Forecast 2012-2024
5.4 Pharmaceutical Taggants Market Forecast 2012-2024
5.5 Pharmaceutical Hologram/OVD Market Forecast 2012-2024
5.6 Other Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2012-2024

6. Leading National Markets 2014-2024

6.1 Pharmaceutical Counterfeiting: A Global Conundrum
6.1.1 How Will National Market Shares Change to 2024?
6.2 Regional Pharmaceutical Anti-counterfeiting Market Forecast, 2014-2024
6.2.1 The US Market
6.2.2 EU5: Europe's Leading Anti-counterfeiting Technology Markets
6.2.3 Japan: Uptake of Key Technologies Important for Market Growth
6.2.4 China: Set to See High Growth Rates Continue Until 2017
6.2.5 India: New Mandates will Help Deter Counterfeiters
6.2.5.1 Collaboration with the WHO will Help Regain Consumer Confidence in Pharma Products
6.2.6 Brazil: South America's Largest Pharmaceutical Market
6.2.7 Russia: Highest Per-Capita Spending on Healthcare of All the BRIC Nations

7. Issues Affecting the Pharmaceutical Anti-counterfeiting Technologies Market

7.1 SWOT Analysis of the Pharmaceutical Anti-counterfeiting Technologies Market, 2014-2024
7.2 Strengths
7.2.1 Growing Interest from Pharmaceutical Companies in Tackling Counterfeiting
7.2.1.1 AstraZeneca
7.2.1.2 GlaxoSmithKline
7.2.1.3 Johnson & Johnson
7.2.1.4 Novartis
7.2.1.5 Pfizer
7.2.1.6 Sanofi
7.2.2 Organisations Promoting the Awareness and Implementation of Anti-Counterfeiting Solutions
7.2.2.1 Anti-counterfeiting and Product Protection Programme (A-CAPPP)
7.2.2.2 Anti-counterfeiting Group (ACG)
7.2.2.3 Brazil's National Health Surveillance Agency (ANVISA)
7.2.2.4 Canadian Anti-counterfeiting Network (CACN)
7.2.2.5 Center for Healthcare Supply Chain Research
7.2.2.6 European Alliance for Access to Safe Medicines (EAASM)
7.2.2.7 European Federation of Pharmaceutical Industries and Associations (EFPIA)
7.2.2.8 International Anti-counterfeiting Coalition (IACC)
7.2.2.9 International Authentication Association (IAA)
7.2.2.10 The Pharmaceutical Security Institute (PSI)
7.2.3 Track-and-Trace Solutions Boosting Supply Chain Efficiency
7.2.4 New Technologies Providing More Comprehesive Anti-Counterfeiting Protection
7.2.5 Litigation Proceedings over Counterfeit Products Affecting Profitability
7.3 Weaknesses
7.3.1 The Lack of Standardisation Across the Industry as a Whole Will Impede Technology Adoption
7.3.2. Insufficient Quantitative Measurement of the Effectiveness of Anti-counterfeiting Technologies
7.3.2.1 Complexity of Factors Influencing Drug Revenue Makes Quantifying Commercial Impact of Anti-counterfeiting Technologies Difficult
7.3.3 Technology Reliability and the Ease of Integration into Manufacturing Processes
7.3.4 Lack of Cooperation Between Various Governmental Organisations Aids Drug
Counterfeiters
7.4 Opportunities
7.4.1 Constantly Evolving Technologies Allows for Product Innovation
7.4.2 Anti-counterfeiting Technologies for the Prevention of Online Fraud
7.5 Threats
7.5.1 The High Volume of Counterfeiting Activities Could Devalue Anti-counterfeiting
Solutions
7.5.2 Developing Countries Lack Infrastructure to Effectively Deal with Counterfeiting
7.5.3 Pace of Innovation May Not Keep up with the Counterfeiters
7.6 STEP Analysis of the Pharmaceutical Anti-counterfeiting Technologies Market, 2014-2024
7.6.1 Social Factors
7.6.1.1 The Weak Enforcement of Legislation
7.6.1.2 Corruption: A Hindrance to Eradicating Pharmaceutical Counterfeiting
7.6.1.3 Changing Public Perception and Consumer Education
7.6.1.4 Concerns Over Information Privacy
7.6.2 Technological Factors
7.6.2.1 Smartphone Read and Verify: A Customer Empowerment Tool
7.6.2.2 US FDA's Counterfeit Detection Device
7.6.2.3 UV and IR Inks Being Used Covertly for Increased Security
7.6.2.4 Bokode: A Potential Replacement for Barcodes?
7.6.2.5 SigNature DNA
7.6.3 Economic Factors
7.6.3.1 Implementation Costs of Anti-counterfeiting Technologies
7.6.3.2 Anti-counterfeiting Technologies Require R&D Investment
7.6.4 Political Factors
7.6.4.1 World Health Organization: The IMPACT Programme
7.6.4.2 Anti-Counterfeiting Trade Agreement (ACTA)
7.6.4.3 The Fagan Civil Case: Effects of Litigation on Players in the Drug Supply Chain
7.6.4.4 Legislations for Supply Chain Security
7.6.4.5 E-pedigree: A Catalyst for Product Serialisation
7.6.4.5.1 E-pedigree: Challenges Involved in Implementation
7.6.4.5.2 EU and the US: Differing Supply Chain Authentication
7.6.4.6 UK MHRA: Falsified Medical Products Strategy
7.6.4.7 The EU's Falsified Medicines Directive

8. Expert Opinions

8.1 Interview with Dr Fred Jordan, Chief Executive Officer, AlpVision
8.1.1 Current State of Counterfeiting in the Pharmaceutical Industry
8.1.2 AlpVison's Key Technologies and Strategies for Combating Counterfeiters
8.1.3 The Future of Anti-counterfeiting Technologies
8.1.4 On Whom do the Responsibilities for Counterfeiting Prevention Lie?
8.1.5 The Major Barriers Facing Implementation of Anti-counterfeiting Technologies
8.1.6 Future Growth Drivers of the Anti-counterfeiting Technologies Market
8.2 Interview with a Spokesperson from a Leading Anti-counterfeiting Technologies Company Based in the US.
8.2.1 On the Threats Posed by Counterfeit Products
8.2.2 Keeping Up with the Counterfeiters: An Impossible Task?
8.2.3 Duty of Care
8.2.4 DNA Technology: The Innovation Needed to Defeat Counterfeiting?
8.2.5 Future Prospects of the Pharma Anti-counterfeiting Industry

9. Conclusion

9.1 The Pharmaceutical Anti-counterfeiting Technologies Industry 2014-2024
9.2 Government Mandates Will Fuel Growth in the Market
9.3 The US Will Continue to Dominate the Market
9.4 New Directives Will Ensure Track-and-Trace Market Leadership
9.5 European Preference for Mandated 2D Barcode Technology
9.6 Improved Regulation of Online Pharmacies Necessary for Anti-counterfeiting Technologies to be Effective
9.7 Market Expansion Will be Dependent on the Development of Industry-Wide Standards for the Use of the Available Technologies

List of Tables

Table 2.1 Global Reported Incidents of Drug Counterfeiting, 2008-2012
Table 2.2 Classification of Counterfeit Pharmaceutical Products
Table 3.1 Anti-counterfeiting Technologies Used in the Pharmaceutical Industry
Table 3.2 Leading Anti-counterfeiting Security Ink Manufacturers, 2013
Table 3.3 Leading Anti-counterfeiting Holographic Labelling Manufacturers, 2013
Table 3.4 Leading Radio Frequency Identification (RFID) System Manufacturers, 2013
Table 3.5 Leading Pharmaceutical Taggants Manufacturers, 2013
Table 4.1 3M: Revenue ($m) and Revenue Shares (%) by Business Segment, 2012
Table 4.2 Alien Technologies: Types of RFID Readers Produced, 2013
Table 4.3 AlpVision: Products and Applications, 2013
Table 4.4 Angstrom Technologies: Products and Applications, 2013
Table 4.5 Avery Dennison: Revenue ($m) and Revenue Shares (%) by Business Segment, 2012
Table 4.6 Avery Dennison: RFID Products for Use in Pharmaceuticals, 2013
Table 4.7 Colorcon: Product Groups, Sub-groups, and Examples 2013
Table 4.8 Everest Holovision: Products and Applications, 2013
Table 4.9 InkSure Technologies: Products and Applications, 2013
Table 4.10 InkSure Technologies: Historical Revenue ($m, AGR %) 2009-2012
Table 4.11 Intermec: Product Lines and Descriptions, 2013
Table 4.12 Intermec: Historical Revenue ($m, AGR %) 2009-2012
Table 4.13 ThermoFisher Scientific: Historical Revenue ($bn) 2009-2012
Table 4.14 ThermoFisher Scientific: Revenue Shares (%) by Region, 2012
Table 4.15 UPM Raflatac: Product Groups and Descriptions, 2013
Table 4.16 Zebra Technologies: Product Groups and Descriptions, 2013
Table 4.17 Zebra Technologies: Historical Revenue ($m, AGR%) 2009-2012
Table 5.1 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) and Market Shares (%) by Sector, 2012
Table 5.2 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue Forecast ($m, AGR%, CAGR%) by Sector, 2012-2017
Table 5.3 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue Forecast ($m, AGR%, CAGR%) by Sector, 2017-2024
Table 5.4 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue ($m) by Sector, 2012, 2017, 2024
Table 5.5 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Sector, 2012, 2017, 2024
Table 5.6 RFID: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 5.7 Security Printing: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 5.8 Pharmaceutical Taggants: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 5.9 Holograms/OVD: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 5.10 Other Technologies: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.1 The Global Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m, AGR%, CAGR%) by Region, 2012-2017
Table 6.2 The Global Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m, AGR%, CAGR%) by Region, 2017-2024
Table 6.3 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2012, 2017, 2024
Table 6.4 US Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.5 EU5 Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.6 Japanese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.7 Chinese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.8 Indian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%,
CAGR%), 2012-2024
Table 6.9 Brazilian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 6.10 Russian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m, AGR%, CAGR%), 2012-2024
Table 7.1 SWOT Analysis of the Pharmaceutical Anti-counterfeiting Technologies Industry, 2014-2024
Table 7.2 Selected Instances of Counterfeiting Activities, 2012-2013
Table 7.3 Selected Instances of Counterfeiting Activities, 2009-2011
Table 7.4 STEP Analysis for the Pharmaceutical Anti-counterfeiting Technologies Industry, 2014-2024

List of Figures

Figure 2.1 Global Reported Incidents of Drug Counterfeiting, 2008-2012
Figure 2.2 Flow Chart of the Route Taken by Counterfeit Pharma Products Entering the Legal Supply Chain
Figure 3.1 Holograms Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024
Figure 3.2 Basic Components of a RFID System
Figure 3.3 RFID Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024
Figure 3.4 Taggants Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024
Figure 3.5 Barcode Anti-counterfeiting Technologies: Drivers and Restraints, 2014-2024
Figure 4.1 3M: Revenue Shares (%) by Business Segment, 2012
Figure 4.2 Authentix's Global Monitoring Service: A Three Step Program
Figure 4.3 Avery Dennison: Revenue Shares (%) by Business Segment, 2012
Figure 4.4 InkSure Technologies: Historical Revenue ($m) 2009-2012
Figure 4.5 Intermec: Historical Revenue ($m) 2009-2012
Figure 4.6 ThermoFisher Scientific: Historical Revenue ($bn) 2009-2012
Figure 4.7 ThermoFisher Scientific: Revenue Shares (%) by Region, 2012
Figure 4.8 Zebra Technologies: Historical Revenue ($m) 2009-2012
Figure 5.1 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenues ($m) by Sector, 2012
Figure 5.2 The Global Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m), 2012- 2017
Figure 5.3 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue Forecast ($m), 2017-2024
Figure 5.4 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Revenue ($m) by Sector, 2012, 2017, 2024
Figure 5.5 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Sector, 2012
Figure 5.6 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Sector, 2017
Figure 5.7 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Sector, 2024
Figure 5.8 RFID: Revenue Forecast ($m), 2012-2024
Figure 5.9 Security Printing: Revenue Forecast ($m), 2012-2024
Figure 5.10 Pharmaceutical Taggants: Revenue Forecast ($m), 2012-2024
Figure 5.11 Holograms/OVD: Revenue Forecast ($m), 2012-2024
Figure 5.12 Other Technologies Revenue Forecast ($m), 2012-2024
Figure 6.1 US and EU5 Pharmaceutical Anti-counterfeiting Technologies: Revenue Forecast ($m), 2012-2024
Figure 6.2 China, India, Brazil and Russia Pharmaceutical Anti-counterfeiting Technologies Market: Revenue Forecast ($m), 2012-2024
Figure 6.3 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2012
Figure 6.4 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2017
Figure 6.5 The Global Pharmaceutical Anti-counterfeiting Technologies Market: Market Shares (%) by Region, 2024
Figure 6.6 US Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.7 EU5 Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.8 Japanese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.9 Chinese Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.10 Indian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.11 Brazilian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 6.12 Russian Pharmaceutical Anti-counterfeiting Market: Revenue Forecast ($m), 2012-2024
Figure 7.1 EU Supply Chain Authentication Strategy, 2013
Figure 7.2 US Supply Chain Authentication Strategy, 2013
Figure 9.1 Global Pharmaceutical Anti-counterfeiting Market: RFID, Security Printing, Holograms/OVD, and Taggants Revenue Forecast ($m), 2012-2024

Companies Listed

3M
Adhesives Research
Ahura Scientific
Alien Technologies
AlpVision
Altegrity Risk International
American Academy of Pediatrics (AAP)
American Express
AmerisourceBergen
Angstrom Technologies
Anti-Counterfeiting and Product Protection Programme (A-CAPPP)
Anti-Counterfeiting Group (ACG)
Apoteket
Applied DNA Sciences
ARmark Authentication Technologies LLC
AstraZeneca
Australian Therapeutic Goods Administration (TGA)
Authentix
Automation
Avery Dennison
Axway
Baxter
Canadian Anti-Counterfeiting Network (CACN)
Capsugel
Cellular Bioengineering Inc.
Center for Healthcare Supply Chain Research
Center for Medicine in the Public Interest (US)
CFC International
Chesapeake
Colorcon
Cortegra
Covectra
Digital China
Directorate General of Foreign Trade [India]
Domino
Drugs Standard Control Organisation
DuPont
European Alliance for Access to Safe Medicines (EAASM)
European Commission
European Directorate for the Quality of Medicines and Healthcare (EDQM),
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Medicines Agency
Europol
Everest Holovisions
GlaxoSmithKline (GSK)
Google
Healthcare Distribution Management Association (HDMA)
Heart UK
Hologram Industries
Holomex
HOMAI (hologram manufactures association of India)
Honeywell International
Image Solutions
Impinj Inc
Ingenia Technology
InkSure Technologies
Intermec/ Interface Mechanisms
International Anti-counterfeiting Association (IAA)
International Anti-Counterfeiting Coalition (IACC)
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
International Ink Company
International Medical Products Anti-Counterfeiting Taskforce (IMPACT)
International Policy Network
Interpol
Japanese Pharmaceutical Manufacturers Association (JPMA)
Johnson & Johnson
Kodak
Loughborough University
LaserLock
Massachusetts Institute of Technology (MIT)
MasterCard
Medicines and Healthcare products Regulatory Agency (MHRA)
Medicrime Convention Council
Menasha Corporation
MicroTag Temed Ltd
Microtrace Solutions
Motorola
NanoGuardian
NanoInk Inc.
Nanotech Security Corp.
National Agency for Food and Drug Administration and Control (NAFDAC) [Nigeria]
National Association of Boards of Pharmacy (NABP)
National Health Surveillance Agency (ANVISA)
Neri Labels
Novartis
Novavision
OEP Technologie BV
One Equity Partners
OpSec Security
Organisation for Economic Co-operation and Development (OECD)
Pacific Holographics
Paralec Inc
Partner for Safe Medicines (PSM) India
Pera Innovations
Pfizer
Pharmaceutical Research and Manufacturers of America (PhRMA)
PharmaSecure
Quality Brands Protection Committee (QBPC) [China]
Reckitt Benckiser
Roche
Royal Pharmaceutical Society of Great Britain (RPSGB)
Sanofi
Savi Technology
ScanSource
Scientific Protein Laboratories (SPL)
SICPA
Siemens
Smartrac
South Dakota School of Mines and Technology
State Food and Drug Administration (SFDA) [China]
Sun Chemical
Symbol Technologies
Systech
Tagsys RFID
Teva Pharmaceuticals
Texas Instruments
The Caryle Group
The International Hologram Manufacturers Association
The Patients Association (UK)
The Pharmaceutical Security Institute (PSI)
ThermoFisher Scientific
TruTag Technologies
United Nations
University of South Dakota
UPM
UPM Kymmene
UPM Raflatac
UPM Rafsec z
US Center for Safe Internet Pharmacies (CSIP)
US Food and Drugs Agency (FDA)
US Pharmacopeial Convention (USP)
Visa
Vocollect Inc
Voxtel
Webscan
World Customs Organization
World Health Organization (WHO)
World Intellectual Property Organization (WIPO)
Zebra Technologies

Read the full report:
Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024
http://www.reportbuyer.com/pharma_healthcare/management_strategy/pharmaceutical_anti_counterfeiting_technologies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

@ThingsExpo Stories
DevOps Summit 2015 New York, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that it is now accepting Keynote Proposals. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long development cycles that produce software that is obsolete at launch. DevOps may be disruptive, but it is essential.
The 3rd International Internet of @ThingsExpo, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that its Call for Papers is now open. The Internet of Things (IoT) is the biggest idea since the creation of the Worldwide Web more than 20 years ago.
Connected devices and the Internet of Things are getting significant momentum in 2014. In his session at Internet of @ThingsExpo, Jim Hunter, Chief Scientist & Technology Evangelist at Greenwave Systems, examined three key elements that together will drive mass adoption of the IoT before the end of 2015. The first element is the recent advent of robust open source protocols (like AllJoyn and WebRTC) that facilitate M2M communication. The second is broad availability of flexible, cost-effective storage designed to handle the massive surge in back-end data in a world where timely analytics is e...
"There is a natural synchronization between the business models, the IoT is there to support ,” explained Brendan O'Brien, Co-founder and Chief Architect of Aria Systems, in this SYS-CON.tv interview at the 15th International Cloud Expo®, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
The Internet of Things will put IT to its ultimate test by creating infinite new opportunities to digitize products and services, generate and analyze new data to improve customer satisfaction, and discover new ways to gain a competitive advantage across nearly every industry. In order to help corporate business units to capitalize on the rapidly evolving IoT opportunities, IT must stand up to a new set of challenges. In his session at @ThingsExpo, Jeff Kaplan, Managing Director of THINKstrategies, will examine why IT must finally fulfill its role in support of its SBUs or face a new round of...
The BPM world is going through some evolution or changes where traditional business process management solutions really have nowhere to go in terms of development of the road map. In this demo at 15th Cloud Expo, Kyle Hansen, Director of Professional Services at AgilePoint, shows AgilePoint’s unique approach to dealing with this market circumstance by developing a rapid application composition or development framework.

ARMONK, N.Y., Nov. 20, 2014 /PRNewswire/ --  IBM (NYSE: IBM) today announced that it is bringing a greater level of control, security and flexibility to cloud-based application development and delivery with a single-tenant version of Bluemix, IBM's platform-as-a-service. The new platform enables developers to build ap...

An entirely new security model is needed for the Internet of Things, or is it? Can we save some old and tested controls for this new and different environment? In his session at @ThingsExpo, New York's at the Javits Center, Davi Ottenheimer, EMC Senior Director of Trust, reviewed hands-on lessons with IoT devices and reveal a new risk balance you might not expect. Davi Ottenheimer, EMC Senior Director of Trust, has more than nineteen years' experience managing global security operations and assessments, including a decade of leading incident response and digital forensics. He is co-author of t...
Building low-cost wearable devices can enhance the quality of our lives. In his session at Internet of @ThingsExpo, Sai Yamanoor, Embedded Software Engineer at Altschool, provided an example of putting together a small keychain within a $50 budget that educates the user about the air quality in their surroundings. He also provided examples such as building a wearable device that provides transit or recreational information. He then reviewed the resources available to build wearable devices at home including open source hardware, the raw materials required and the options available to power s...
The Internet of Things is not new. Historically, smart businesses have used its basic concept of leveraging data to drive better decision making and have capitalized on those insights to realize additional revenue opportunities. So, what has changed to make the Internet of Things one of the hottest topics in tech? In his session at @ThingsExpo, Chris Gray, Director, Embedded and Internet of Things, discussed the underlying factors that are driving the economics of intelligent systems. Discover how hardware commoditization, the ubiquitous nature of connectivity, and the emergence of Big Data a...
The Internet of Things promises to transform businesses (and lives), but navigating the business and technical path to success can be difficult to understand. In his session at @ThingsExpo, Sean Lorenz, Technical Product Manager for Xively at LogMeIn, demonstrated how to approach creating broadly successful connected customer solutions using real world business transformation studies including New England BioLabs and more.
We certainly live in interesting technological times. And no more interesting than the current competing IoT standards for connectivity. Various standards bodies, approaches, and ecosystems are vying for mindshare and positioning for a competitive edge. It is clear that when the dust settles, we will have new protocols, evolved protocols, that will change the way we interact with devices and infrastructure. We will also have evolved web protocols, like HTTP/2, that will be changing the very core of our infrastructures. At the same time, we have old approaches made new again like micro-services...
Enthusiasm for the Internet of Things has reached an all-time high. In 2013 alone, venture capitalists spent more than $1 billion dollars investing in the IoT space. With "smart" appliances and devices, IoT covers wearable smart devices, cloud services to hardware companies. Nest, a Google company, detects temperatures inside homes and automatically adjusts it by tracking its user's habit. These technologies are quickly developing and with it come challenges such as bridging infrastructure gaps, abiding by privacy concerns and making the concept a reality. These challenges can't be addressed w...
The Domain Name Service (DNS) is one of the most important components in networking infrastructure, enabling users and services to access applications by translating URLs (names) into IP addresses (numbers). Because every icon and URL and all embedded content on a website requires a DNS lookup loading complex sites necessitates hundreds of DNS queries. In addition, as more internet-enabled ‘Things' get connected, people will rely on DNS to name and find their fridges, toasters and toilets. According to a recent IDG Research Services Survey this rate of traffic will only grow. What's driving t...
The Internet of Things is a misnomer. That implies that everything is on the Internet, and that simply should not be - especially for things that are blurring the line between medical devices that stimulate like a pacemaker and quantified self-sensors like a pedometer or pulse tracker. The mesh of things that we manage must be segmented into zones of trust for sensing data, transmitting data, receiving command and control administrative changes, and peer-to-peer mesh messaging. In his session at @ThingsExpo, Ryan Bagnulo, Solution Architect / Software Engineer at SOA Software, focused on desi...
Today’s enterprise is being driven by disruptive competitive and human capital requirements to provide enterprise application access through not only desktops, but also mobile devices. To retrofit existing programs across all these devices using traditional programming methods is very costly and time consuming – often prohibitively so. In his session at @ThingsExpo, Jesse Shiah, CEO, President, and Co-Founder of AgilePoint Inc., discussed how you can create applications that run on all mobile devices as well as laptops and desktops using a visual drag-and-drop application – and eForms-buildi...
"For over 25 years we have been working with a lot of enterprise customers and we have seen how companies create applications. And now that we have moved to cloud computing, mobile, social and the Internet of Things, we see that the market needs a new way of creating applications," stated Jesse Shiah, CEO, President and Co-Founder of AgilePoint Inc., in this SYS-CON.tv interview at 15th Cloud Expo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
The Industrial Internet revolution is now underway, enabled by connected machines and billions of devices that communicate and collaborate. The massive amounts of Big Data requiring real-time analysis is flooding legacy IT systems and giving way to cloud environments that can handle the unpredictable workloads. Yet many barriers remain until we can fully realize the opportunities and benefits from the convergence of machines and devices with Big Data and the cloud, including interoperability, data security and privacy.
Things are being built upon cloud foundations to transform organizations. This CEO Power Panel at 15th Cloud Expo, moderated by Roger Strukhoff, Cloud Expo and @ThingsExpo conference chair, addressed the big issues involving these technologies and, more important, the results they will achieve. Rodney Rogers, chairman and CEO of Virtustream; Brendan O'Brien, co-founder of Aria Systems, Bart Copeland, president and CEO of ActiveState Software; Jim Cowie, chief scientist at Dyn; Dave Wagstaff, VP and chief architect at BSQUARE Corporation; Seth Proctor, CTO of NuoDB, Inc.; and Andris Gailitis, C...
Since 2008 and for the first time in history, more than half of humans live in urban areas, urging cities to become “smart.” Today, cities can leverage the wide availability of smartphones combined with new technologies such as Beacons or NFC to connect their urban furniture and environment to create citizen-first services that improve transportation, way-finding and information delivery. In her session at @ThingsExpo, Laetitia Gazel-Anthoine, CEO of Connecthings, will focus on successful use cases.